A comparison of the imaging features of early stage primary lung cancer in patients treated with surgery, SABR and microwave ablation
Stereotactic Ablative Radiotherapy (SABR) and percutaneous microwave ablation (PMWA) are now being performed in patients deemed “medically inoperable” with non-small cell lung cancer (NSCLC). The majority of these patients are treated without ground truth histology, relying on imaging to establish t...
Main Authors: | Talwar, A, Jenko, N, Sarim, M, Enescu, M, Whybra, P, Willaime, J, Pickup, L, Hickes, W, Gooding, M, Boukerroui, D, Rahman, N, Kadir, T, Gleeson, F |
---|---|
Format: | Conference item |
Published: |
BMJ Publishing Group
2017
|
Similar Items
-
Pulmonary nodules: assessing the repeatability of imaging biomarkers of malignancy
by: Talwar, A, et al.
Published: (2016) -
Pulmonary nodules: Assessing the imaging biomarkers of malignancy in a "coffee-break"
by: Talwar, A, et al.
Published: (2018) -
The SABRE project and the SABRE Proof-of-Principle
by: M. Antonello, et al.
Published: (2019-04-01) -
Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
by: Inderdeep Dhaliwal, et al.
Published: (2022-04-01) -
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)